Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.56 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.56 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.56 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.56 |
| ▸ | CBFB | Q13951 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.50 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.50 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.49 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8577441 | 0.88 | MEN1 (0.68) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL4236970 | 0.83 | MAPT (0.49) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL8576078 | 0.82 | MEN1 (0.66) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL1176635 | 0.81 | MEN1 (0.69) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL24490019 | 0.81 | GAA (0.66) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL9674 | 0.80 | MAPT (0.81) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL8032430 | 0.80 | MEN1 (0.50) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL17919672 | 0.79 | TDP1 (0.64) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL1808465 | 0.79 | MEN1 (0.58) | MEN1KMT2AMAPTRAB9AKDM4E | |
| SCHEMBL8549110 | 0.79 | RAB9A (0.62) | MEN1KMT2AMAPTRAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023042914-A1 | PYRROLIDINE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-03-23 | — | — | WO | disclosed |
| US-9796705-B2 | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases | MERCK SHARP & DOHME CORP. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170008879-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2017-01-12 | — | — | US | disclosed |
| EP-2545060-B1 | FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME (US) | 2015-11-25 | — | — | EP | disclosed |
| US-20130156731-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS | SCHERING CORPORATION | 2013-06-20 | — | — | US | disclosed |
| US-20120276047-A1 | FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES | SCHERING CORPORATION | 2012-11-01 | — | — | US | disclosed |
| CN-101928280-B | Pepperphentonamine derivative containing naphthalene rings | GUANGZHOU ZHONGWEI BIOTECHNOLOGY CO LTD | 2012-09-12 | — | — | CN | disclosed |
| US-20110223134-A1 | FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME LLC | 2011-09-15 | — | — | US | disclosed |
| WO-2011112429-A1 | FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | SCHERING CORPORATION (US) | 2011-09-15 | — | — | WO | disclosed |
| CN-101928280-A | Pepperphentonamine derivative containing naphthalene rings | KBP BIOSCIENCES CO LTD | 2010-12-29 | — | — | CN | disclosed |
| US-20070299101-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME CORP. | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156731-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS | HAVCR2, ELOC, ZC3HAV1 | MEN1 2525/4885KMT2A 1061/4885MAPT 1720/4885 |
| US-20170008879-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | ZC3HAV1, HAVCR2, ZC3HAV1L | MEN1 2324/4885KMT2A 1933/4885MAPT 1146/4885 |
| US-20070299101-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | LDLR, APOB, FFAR1 | MEN1 3094/4885KMT2A 4056/4885MAPT 2051/4885 |
| US-20110223134-A1 | FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | FOXM1, ZC3HAV1L, C1S | MEN1 734/4885KMT2A 3780/4885MAPT 2787/4885 |
| US-20120276047-A1 | FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES | ZC3HAV1, HAVCR2, ZC3HAV1L | MEN1 1853/4885KMT2A 2862/4885MAPT 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.